INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista JRG de Estudos Acadêmicos |
Texto Completo: | http://revistajrg.com/index.php/jrg/article/view/279 |
Resumo: | Erectile dysfunction (DE) is known as a man's difficulty in obtaining or maintaining an erection, may have as causes some diseases and conditions such as: depression, diabetes, arterial hypertension, high cholesterol, obesity, coronary disease, disease of Parkinson's, prostate cancer treatment, anabolic steroid consumption, spinal cord injuries, drug addiction, alcoholism, and even stress and anxiety. An accidental discovery of one of the most famous pharmaceuticals in the pharmaceutical industry began at the end of the 80, when the American laboratory Pfizer, who had invested heavily in research and testing to find a drug for hypertension Pulmonary and angina pectoris. So, these studies were terminated in 1992, because the first results suggested that the drug had a small effect on angina. However, it was noted some properties in the Sildenafil citrate that could be a new light on the treatment of erectile dysfunctions. In the 30-day period, in the region's drugstores, approximately 800 individuals aged between 17 and 85 years were treated, where it can be verified that not only people with erectile dysfunction make use of sildenafil and tadalafila. Where 51% of these individuals aged between 17 and 30 years make use of these regular medications, in most cases if they are for recreational use, without a medical indication only for personal reasons such as: increase libido and improve sexual performance. |
id |
JRG_5ad6a67d0df44b3f06e07b8c7ad4296f |
---|---|
oai_identifier_str |
oai:ojs2.revistajrg.com:article/279 |
network_acronym_str |
JRG |
network_name_str |
Revista JRG de Estudos Acadêmicos |
repository_id_str |
|
spelling |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERSINDICAÇÃO DE USO INDISCRIMINADO DE SILDENAFILA E TADALAFILA POR JOVENSDisfunção erétil. Sildenafila. Tadalafila.Erectile dysfunction. Sildenafil. tadalafilErectile dysfunction (DE) is known as a man's difficulty in obtaining or maintaining an erection, may have as causes some diseases and conditions such as: depression, diabetes, arterial hypertension, high cholesterol, obesity, coronary disease, disease of Parkinson's, prostate cancer treatment, anabolic steroid consumption, spinal cord injuries, drug addiction, alcoholism, and even stress and anxiety. An accidental discovery of one of the most famous pharmaceuticals in the pharmaceutical industry began at the end of the 80, when the American laboratory Pfizer, who had invested heavily in research and testing to find a drug for hypertension Pulmonary and angina pectoris. So, these studies were terminated in 1992, because the first results suggested that the drug had a small effect on angina. However, it was noted some properties in the Sildenafil citrate that could be a new light on the treatment of erectile dysfunctions. In the 30-day period, in the region's drugstores, approximately 800 individuals aged between 17 and 85 years were treated, where it can be verified that not only people with erectile dysfunction make use of sildenafil and tadalafila. Where 51% of these individuals aged between 17 and 30 years make use of these regular medications, in most cases if they are for recreational use, without a medical indication only for personal reasons such as: increase libido and improve sexual performance.A disfunção erétil (DE) é conhecida como uma dificuldade do homem em obter ou manter uma ereção, podem ter como causas algumas doenças e condições tais como: depressão, diabetes, hipertensão arterial, colesterol elevado, obesidade, doença coronária, doença de Parkinson, tratamento do cancro da próstata, consumo de esteroides anabolizantes, lesões na medula espinhal, toxicodependência, alcoolismo, e até mesmo stress e ansiedade. Uma descoberta acidental de um dos medicamentos mais famosos da indústria farmacêutica teve início no final da década de 80, quando o laboratório americano Pfizer, que havia investido muito em pesquisas e testes para encontrar um medicamento para hipertensão pulmonar e angina do peito. Então esses estudos foram encerrados em 1992, porque os primeiros resultados sugeriram que a droga tinha um pequeno efeito sobre a angina. Entretanto, foi notado algumas propriedades no citrato de sildenafila que poderia ser uma nova luz sobre o tratamento de disfunções eréteis. No período de 30 dias, em drogarias da região foram atendidos em média cerca de 800 indivíduos com idade entre 17 a 85 anos, onde se pode comprovar que não somente pessoas com disfunção erétil fazem o uso da sildenafila e tadalafila. Onde 51% desses indivíduos com idade entre 17 a 30 anos fazem uso desses medicamentos regulares, na maioria dos casos se dá para uso recreativo, sem uma indicação médica somente por questões pessoais como: aumentar a libido e para a melhora do desempenho sexual.Editora JRG2021-07-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigo avaliado pelos Paresapplication/pdfhttp://revistajrg.com/index.php/jrg/article/view/27910.5281/zenodo.5093826JRG Journal of Academic Studies; Vol. 4 No. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77JRG Journal of Academic Studies ; Vol. 4 Núm. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77JRG Journal of Academic Studies; V. 4 N. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77Revista JRG de Estudos Acadêmicos ; v. 4 n. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-772595-166110.29327/257411.4.9-1reponame:Revista JRG de Estudos Acadêmicosinstname:Editora JRGinstacron:JRGporhttp://revistajrg.com/index.php/jrg/article/view/279/369https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRezende, Patrícia Mendes Coimbra, Marcus Vinicius da Silva 2022-03-08T14:02:39Zoai:ojs2.revistajrg.com:article/279Revistahttp://revistajrg.com/index.php/jrgPRIhttp://revistajrg.com/index.php/jrg/oaiprofessorjonas@gmail.com||2595-16612595-1661opendoar:2022-03-08T14:02:39Revista JRG de Estudos Acadêmicos - Editora JRGfalse |
dc.title.none.fl_str_mv |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS INDICAÇÃO DE USO INDISCRIMINADO DE SILDENAFILA E TADALAFILA POR JOVENS |
title |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS |
spellingShingle |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS Rezende, Patrícia Mendes Disfunção erétil. Sildenafila. Tadalafila. Erectile dysfunction. Sildenafil. tadalafil |
title_short |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS |
title_full |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS |
title_fullStr |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS |
title_full_unstemmed |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS |
title_sort |
INDISCRIMINATED INDICATION USE OF SILDENAFILA AND TADALAFILA BY YOUNGERS |
author |
Rezende, Patrícia Mendes |
author_facet |
Rezende, Patrícia Mendes Coimbra, Marcus Vinicius da Silva |
author_role |
author |
author2 |
Coimbra, Marcus Vinicius da Silva |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Rezende, Patrícia Mendes Coimbra, Marcus Vinicius da Silva |
dc.subject.por.fl_str_mv |
Disfunção erétil. Sildenafila. Tadalafila. Erectile dysfunction. Sildenafil. tadalafil |
topic |
Disfunção erétil. Sildenafila. Tadalafila. Erectile dysfunction. Sildenafil. tadalafil |
description |
Erectile dysfunction (DE) is known as a man's difficulty in obtaining or maintaining an erection, may have as causes some diseases and conditions such as: depression, diabetes, arterial hypertension, high cholesterol, obesity, coronary disease, disease of Parkinson's, prostate cancer treatment, anabolic steroid consumption, spinal cord injuries, drug addiction, alcoholism, and even stress and anxiety. An accidental discovery of one of the most famous pharmaceuticals in the pharmaceutical industry began at the end of the 80, when the American laboratory Pfizer, who had invested heavily in research and testing to find a drug for hypertension Pulmonary and angina pectoris. So, these studies were terminated in 1992, because the first results suggested that the drug had a small effect on angina. However, it was noted some properties in the Sildenafil citrate that could be a new light on the treatment of erectile dysfunctions. In the 30-day period, in the region's drugstores, approximately 800 individuals aged between 17 and 85 years were treated, where it can be verified that not only people with erectile dysfunction make use of sildenafil and tadalafila. Where 51% of these individuals aged between 17 and 30 years make use of these regular medications, in most cases if they are for recreational use, without a medical indication only for personal reasons such as: increase libido and improve sexual performance. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-07-12 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigo avaliado pelos Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://revistajrg.com/index.php/jrg/article/view/279 10.5281/zenodo.5093826 |
url |
http://revistajrg.com/index.php/jrg/article/view/279 |
identifier_str_mv |
10.5281/zenodo.5093826 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
http://revistajrg.com/index.php/jrg/article/view/279/369 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Editora JRG |
publisher.none.fl_str_mv |
Editora JRG |
dc.source.none.fl_str_mv |
JRG Journal of Academic Studies; Vol. 4 No. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77 JRG Journal of Academic Studies ; Vol. 4 Núm. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77 JRG Journal of Academic Studies; V. 4 N. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77 Revista JRG de Estudos Acadêmicos ; v. 4 n. 9 (2021): Revista JRG de Estudos Acadêmicos ; 66-77 2595-1661 10.29327/257411.4.9-1 reponame:Revista JRG de Estudos Acadêmicos instname:Editora JRG instacron:JRG |
instname_str |
Editora JRG |
instacron_str |
JRG |
institution |
JRG |
reponame_str |
Revista JRG de Estudos Acadêmicos |
collection |
Revista JRG de Estudos Acadêmicos |
repository.name.fl_str_mv |
Revista JRG de Estudos Acadêmicos - Editora JRG |
repository.mail.fl_str_mv |
professorjonas@gmail.com|| |
_version_ |
1797068983383359488 |